Literature DB >> 29669834

Generation of Recombinant Rotaviruses Expressing Fluorescent Proteins by Using an Optimized Reverse Genetics System.

Satoshi Komoto1, Saori Fukuda2, Tomihiko Ide2, Naoto Ito3,4, Makoto Sugiyama3,4, Tetsushi Yoshikawa5, Takayuki Murata2, Koki Taniguchi2.   

Abstract

An entirely plasmid-based reverse genetics system for rotaviruses was established very recently. We improved the reverse genetics system to generate recombinant rotavirus by transfecting only 11 cDNA plasmids for its 11 gene segments under the condition of increasing the ratio of the cDNA plasmids for NSP2 and NSP5 genes. Utilizing this highly efficient system, we then engineered infectious recombinant rotaviruses expressing bioluminescent (NanoLuc luciferase) and fluorescent (enhanced green fluorescent protein [EGFP] and mCherry) reporters. These recombinant rotaviruses expressing reporters remained genetically stable during serial passages. Our reverse genetics approach and recombinant rotaviruses carrying reporter genes will be great additions to the tool kit for studying the molecular virology of rotavirus and for developing future next-generation vaccines and expression vectors.IMPORTANCE Rotavirus is one of the most important pathogens causing severe gastroenteritis in young children worldwide. In this paper, we describe a robust and simple reverse genetics system based on only rotavirus cDNAs and its application for engineering infectious recombinant rotaviruses harboring bioluminescent (NanoLuc) and fluorescent (EGFP and mCherry) protein genes. This highly efficient reverse genetics system and recombinant group A rotaviruses expressing reporters could be powerful tools for the study of different aspects of rotavirus replication. Furthermore, they may be useful for next-generation vaccine production for this medically important virus.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  NSP2; NSP5; fluorescent proteins; reporters; reverse genetics; rotavirus

Mesh:

Substances:

Year:  2018        PMID: 29669834      PMCID: PMC6002737          DOI: 10.1128/JVI.00588-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Effects of intrabodies specific for rotavirus NSP5 during the virus replicative cycle.

Authors:  Fulvia Vascotto; Michela Campagna; Michela Visintin; Antonino Cattaneo; Oscar R Burrone
Journal:  J Gen Virol       Date:  2004-11       Impact factor: 3.891

2.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

3.  Entirely plasmid-based reverse genetics system for rotaviruses.

Authors:  Yuta Kanai; Satoshi Komoto; Takahiro Kawagishi; Ryotaro Nouda; Naoko Nagasawa; Misa Onishi; Yoshiharu Matsuura; Koki Taniguchi; Takeshi Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

4.  Localization of rotavirus antigens in infected cells by ultrastructural immunocytochemistry.

Authors:  B L Petrie; D Y Graham; H Hanssen; M K Estes
Journal:  J Gen Virol       Date:  1982-12       Impact factor: 3.891

5.  Structural analysis of electrophoretic variation in the genome profiles of rotavirus field isolates.

Authors:  I N Clarke; M A McCrae
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

6.  Ability to induce p53 and caspase-mediated apoptosis in primary CD4+ T cells is variable among primary isolates of human immunodeficiency virus type 1.

Authors:  Satoshi Komoto; Masanobu Kinomoto; Haruko Horikoshi; Miki Shiraga; Takeshi Kurosu; Tetsu Mukai; Wattana Auwanit; Toru Otake; Isao Oishi; Kazuyoshi Ikuta
Journal:  AIDS Res Hum Retroviruses       Date:  2002-04-10       Impact factor: 2.205

7.  Two non-structural rotavirus proteins, NSP2 and NSP5, form viroplasm-like structures in vivo.

Authors:  E Fabbretti; I Afrikanova; F Vascotto; O R Burrone
Journal:  J Gen Virol       Date:  1999-02       Impact factor: 3.891

8.  Generation of an Avian-Mammalian Rotavirus Reassortant by Using a Helper Virus-Dependent Reverse Genetics System.

Authors:  Reimar Johne; Jochen Reetz; Benedikt B Kaufer; Eva Trojnar
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

9.  Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2016-05-01       Impact factor: 9.079

10.  Minimum requirements for bluetongue virus primary replication in vivo.

Authors:  Eiko Matsuo; Polly Roy
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

View more
  27 in total

1.  The 13th International Double-Stranded RNA Virus Symposium, Houffalize, Belgium, 24 to 28 September 2018.

Authors:  Ulrich Desselberger
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Development of Stable Rotavirus Reporter Expression Systems.

Authors:  Yuta Kanai; Takahiro Kawagishi; Ryotaro Nouda; Misa Onishi; Pimfhun Pannacha; Jeffery A Nurdin; Keiichiro Nomura; Yoshiharu Matsuura; Takeshi Kobayashi
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  Generation of Recombinant Rotavirus Expressing NSP3-UnaG Fusion Protein by a Simplified Reverse Genetics System.

Authors:  Asha A Philip; Jacob L Perry; Heather E Eaton; Maya Shmulevitz; Joseph M Hyser; John T Patton
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

4.  Expression of Separate Heterologous Proteins from the Rotavirus NSP3 Genome Segment Using a Translational 2A Stop-Restart Element.

Authors:  Asha A Philip; John T Patton
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

5.  Generation of Infectious Recombinant Human Rotaviruses from Just 11 Cloned cDNAs Encoding the Rotavirus Genome.

Authors:  Satoshi Komoto; Saori Fukuda; Masanori Kugita; Riona Hatazawa; Chitose Koyama; Kazuhiko Katayama; Takayuki Murata; Koki Taniguchi
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 6.  Plasmid-based reverse genetics for probing phosphorylation-dependent viroplasm formation in rotaviruses.

Authors:  Jeanette M Criglar; Sue E Crawford; Mary K Estes
Journal:  Virus Res       Date:  2020-10-11       Impact factor: 3.303

7.  Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus.

Authors:  Yuta Kanai; Misa Onishi; Takahiro Kawagishi; Pimfhun Pannacha; Jeffery A Nurdin; Ryotaro Nouda; Moeko Yamasaki; Tina Lusiany; Pattara Khamrin; Shoko Okitsu; Satoshi Hayakawa; Hirotaka Ebina; Hiroshi Ushijima; Takeshi Kobayashi
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

8.  An Optimized Reverse Genetics System Suitable for Efficient Recovery of Simian, Human, and Murine-Like Rotaviruses.

Authors:  Liliana Sánchez-Tacuba; Ningguo Feng; Nathan J Meade; Kenneth H Mellits; Philippe H Jaïs; Linda L Yasukawa; Theresa K Resch; Baoming Jiang; Susana López; Siyuan Ding; Harry B Greenberg
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

9.  Rotavirus as an Expression Platform of Domains of the SARS-CoV-2 Spike Protein.

Authors:  Asha Ann Philip; John Thomas Patton
Journal:  Vaccines (Basel)       Date:  2021-05-03

Review 10.  Recent advances in rotavirus reverse genetics and its utilization in basic research and vaccine development.

Authors:  Tirth Uprety; Dan Wang; Feng Li
Journal:  Arch Virol       Date:  2021-07-03       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.